Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • A Powerful Community of Patients, Caregivers, and Advocates Gather at the Cancer Research Institute Immunotherapy Patient Summit in New York City

    On Saturday, September 7, 2019, over 275 patients, survivors, caregivers, advocates, and healthcare professionals attended the CRI…

    September 8, 2019| Caroline Offit
  • Sarcoma Awareness Month: Immunotherapy for Sarcoma 2019 Research Update

    July is Sarcoma Awareness Month. As a rare and difficult-to-treat form of cancer, effective drug treatments are…

    July 31, 2019| CRI Staff
  • Behind the Changing Landscape of Chordoma Research and Treatment with Joan Levy, PhD

    Dr. Joan Levy, director of research at the Chordoma Foundation, discusses the current state of chordoma research…

    July 30, 2019| Arthur N. Brodsky, PhD
  • An Informative and Uplifting Day of Learning at the Cancer Research Institute Immunotherapy Patient Summit in Boston

    More than 200 patients, survivors, caregivers, advocates, and healthcare professionals gathered at Dana-Farber Cancer Institute for the…

    July 29, 2019| Caroline Offit
  • How Immunotherapy Is Making an Impact in Breast Cancer

    We spoke with Rebecca A. Shatsky, MD, about the current treatment landscape for patients with breast cancer,…

    July 18, 2019| Arthur N. Brodsky, PhD
  • Rick

    Rick’s Immunotherapy Story

    Kidney Cancer |  Diagnosed 2016 They use the term ‘super-responder,’ I like to think of myself as super-cured.”…
    July 2, 2019| CRI Staff
  • Kicking Off the 2019 CRI Immunotherapy Patient Summit Series: A Saturday of Learning and Networking in San Diego

    More than 200 patients, caregivers, and advocates attended an Immunotherapy Patient Summit in San Diego on Saturday,…

    July 1, 2019| Caroline Offit
  • Shirley Dumont

    Shirley Dumont’s Immunotherapy Story

    Bladder Cancer |  Diagnosed 2008 My doctor calls me the ‘bionic woman.’ This is all through immunotherapy. Shirley’s…
    June 28, 2019| CRI Staff
  • CRI Hosts Academic and Industry Experts for “Immuno-Oncology: A Future Look”

    CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June…

    June 25, 2019| Arthur N. Brodsky, PhD
Previous Page
1 … 49 50 51 52 53 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal